
On Holding AG (ONON) was downgraded by Jefferies to Underperform with a $40 price target, citing concerns over peak sales growth in 2025, slowing U.S. expansion, and potential market share shifts to Nike. This bearish view contrasts with ONON's robust second-quarter performance, which featured a 38% currency-adjusted revenue increase and improved margins, prompting several other analysts, including BTIG, Williams Trading, Truist, and UBS, to reiterate Buy ratings with price targets ranging from $69 to $75, reflecting a divergence in analyst sentiment regarding the company's growth trajectory.
On Holding AG (ONON) presents a polarized investment case, underscored by a significant divergence in analyst sentiment. Jefferies has issued a notable downgrade to Underperform with a $40 price target, citing a forward-looking thesis that 2025 will represent peak sales growth. This bearish outlook is predicated on slowing U.S. retail expansion and a potential moderation in sell-in during 2026 as retailers may shift orders back to Nike. Jefferies further projects sales and EBITDA estimates 5% and 10% below consensus, respectively, and anticipates valuation multiple compression due to a limited total addressable market from high pricing and narrow product assortment. This contrasts sharply with the company's recent exceptional performance, including a 38% currency-adjusted revenue increase and significant margin expansion in the second quarter. This robust execution has prompted bullish reiterations from firms like BTIG, Williams Trading, Truist, and UBS, with price targets ranging from $69 to $75. UBS even anticipates a potential upward revision to the company's 28% fiscal 2025 sales growth outlook. A more cautious but still positive stance is held by TD Cowen, which lowered its price target to $60 due to foreign exchange and tariff concerns, highlighting external risks despite maintaining a Buy rating.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.25
Ticker Sentiment